Research Overviewbiofeedback

Biofeedback and Chronic Pain: A Review of the Research

Biofeedback is one of the better-evidenced non-pharmacological approaches for chronic pain. This review examines what the research shows, which conditions respond best, and where significant gaps remain.

By Gyfts Editorial Team 5 September 2024

Reviewed by Dr. Ava Gardner · Integrative Medicine Researcher13 March 2026Research-supported

Biofeedback and Chronic Pain: A Review of the Research — holistic health

Photo by Markus Winkler on Unsplash

Quick answer

Biofeedback for chronic pain has a robust evidence base for headache (tension-type and migraine), TMD, and low back pain. EMG biofeedback, thermal biofeedback, and HRV biofeedback are used across these conditions. Meta-analyses show clinically significant pain reduction and disability improvement. It is recommended in several clinical guidelines as an adjunct to standard care.

Key Takeaways

•Biofeedback has a strong evidence base for tension-type headache, migraine, and TMD
•EMG biofeedback and thermal biofeedback are the most studied forms for pain conditions
•Effects on chronic low back pain are positive, with moderate to strong evidence
•Biofeedback is endorsed in several clinical pain management guidelines
•Mechanisms include muscle relaxation, altered pain perception, and improved autonomic regulation
•Evidence for fibromyalgia and complex regional pain syndrome is promising but requires more research

Overview

Chronic pain — pain persisting beyond three months — affects a substantial proportion of the adult population and represents a significant challenge for both individuals and healthcare systems. Pharmacological management carries risks of dependency, side effects, and diminishing returns, driving interest in evidence-based non-pharmacological approaches. Biofeedback is among the best-evidenced of these.

Which Types of Biofeedback Are Used for Pain?

Three forms are primarily used. EMG biofeedback measures muscle tension and trains its reduction — most relevant for tension headaches, TMD, and musculoskeletal pain. Thermal biofeedback measures peripheral skin temperature and trains vasodilation — primarily used for migraine. HRV biofeedback targets autonomic regulation — relevant across multiple pain conditions due to the relationship between autonomic dysregulation and pain amplification.

Evidence for Specific Conditions

For tension-type headaches, EMG biofeedback has been studied since the 1970s and has one of the most robust evidence bases in the broader headache literature. Multiple RCTs and meta-analyses confirm clinically significant reductions in headache frequency and intensity.

For migraine, a 2007 meta-analysis by Nestoriuc and Martin analysed 55 studies and found biofeedback produced significant reductions in migraine frequency, duration, and intensity, with effects maintained at follow-up. Effect sizes were comparable to those of preventive medication. Thermal biofeedback showed particularly consistent results.

For temporomandibular disorder (TMD), a systematic review by Crider and colleagues found strong evidence for EMG biofeedback reducing pain and jaw muscle tension. For chronic low back pain, a 2017 meta-analysis by Sielski and colleagues found significant reductions in pain intensity and disability ratings, with moderate to strong effect sizes.

Mechanisms

Biofeedback reduces chronic pain through several pathways. The most direct is reducing muscle hypertonicity that contributes to pain — particularly relevant for tension headaches and TMD. At a broader level, improved autonomic regulation (via HRV biofeedback) reduces central sensitisation, a process in which the nervous system becomes amplified in its pain response over time. Biofeedback also consistently improves pain self-efficacy — the individual's belief in their ability to manage their pain — which is independently predictive of better pain outcomes.

Limitations and Evidence Gaps

Most biofeedback pain studies are conducted in specialist research settings, which may not reflect the range of practitioners and conditions in typical clinical practice. Publication bias towards positive results is a known issue in the field. Evidence for fibromyalgia and complex regional pain syndrome (CRPS) is promising but requires larger, better-controlled trials before firm conclusions can be drawn.

Evidence Context

strong

Biofeedback has a well-developed evidence base for chronic pain management, with the strongest data for tension-type headaches, migraine, temporomandibular disorder (TMD), and chronic low back pain. It is recommended in several clinical pain guidelines as an adjunctive intervention.

Safety & Considerations

Biofeedback is non-invasive and safe for most people with chronic pain. It should complement rather than replace medical pain management for complex or severe presentations. Always maintain communication with your treating healthcare team.

Who May Benefit

People researching non-pharmacological options for chronic pain
Clinicians seeking an evidence summary for patient recommendations
Those with tension headaches, migraine, TMD, or chronic back pain specifically

Frequently Asked Questions

Is biofeedback effective for migraine?

Yes — biofeedback for migraine has one of the stronger evidence bases in the pain literature. A meta-analysis by Nestoriuc and Martin found biofeedback equivalent in efficacy to prophylactic migraine medication in several studies, with lasting effects post-treatment. Thermal biofeedback and EMG biofeedback are both used.

How does biofeedback reduce pain?

Biofeedback reduces pain through several mechanisms: reducing muscle tension that contributes to pain (particularly for headaches, TMD, and back pain), improving autonomic regulation and reducing the physiological stress response that amplifies pain perception, and increasing a sense of control and self-efficacy — which itself modulates the pain experience.

References

Written by

Gyfts Editorial Team

Editorial team at Gyfts researching holistic health modalities.

Reviewed by

Dr. Ava Gardner

Integrative Medicine Researcher

MB BCh BAO, MSc Integrative Medicine, MRCGP

Dr. Ava Gardner is a Dublin-based integrative medicine physician with over 15 years of clinical experience bridging conventional general practice and evidence-based complementary care. She holds a Masters in Integrative Medicine from the University of Arizona and has worked extensively in chronic pain management, women's hormonal health, and mind-body medicine. Dr. Gardner reviews health content for Gyfts to ensure clinical accuracy, balanced evidence presentation, and responsible safety guidance across modality and condition pages.

View full profile →

Featured Practitioners

Declan Fitzgerald

Breathwork

Lars Eriksson

Traditional Chinese Medicine

WitchHazel

5.0(1)

Dublin, IE

View Profile

More on Biofeedback

Session Experience

What Happens During a Biofeedback Session?

Biofeedback sessions are structured, technology-assisted, and skills-based. Here is exactly what to expect — from the sensors to the screen to what you will practise between appointments.

10 August 2024

Guide

Biofeedback for Anxiety: What the Evidence Says

Biofeedback uses real-time physiological monitoring to train the nervous system. For anxiety, it has one of the strongest evidence bases among complementary approaches — here is what the research shows.

22 July 2024